The effect of ranitidine on cellular immunity in patients with multiple myeloma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01771458PMID 2289214PMCID PMC11038912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy.

  2009cited by this paper
• Granulocyte function in malignant monoclonal gammopathy.

  2009cited by this paper
• Monocytes and Macrophages

  1996cited by this paper
• Ranitidine improves postoperative suppression of antibody response to preoperative vaccination.

  1992cited by this paper
• Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin‐2 receptors

  1991influential reference
• Complement abnormalities in multiple myeloma.

  1989cited by this paper
• Mononuclear phagocytes.

  1989cited by this paper
• Ranitidine for prevention of postoperative suppression of delayed hypersensitivity.

  1989cited by this paper
• Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity.

  1989cited by this paper
• Hyper-IgE syndrome and H2-receptor blockade.

  1989cited by this paper
• Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis.

  1989cited by this paper
• Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity.

  1989cited by this paper
• Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine).

  1988cited by this paper
• Effect of cimetidine on survival after gastric cancer.

  1988cited by this paper
• Current concepts: immunology. Monocytes and macrophages.

  1988cited by this paper
• IgG subclass concentrations in sera from 200 normal adults and IgG subclass determination of 106 myeloma proteins: an interlaboratory study.

  1988cited by this paper
• How killer cells kill.

  1988cited by this paper
• High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS).

  1988cited by this paper
• What makes a tumor cell metastatic?

  1988cited by this paper
• Alteration of monocyte function following major injury.

  1988cited by this paper
• Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.

  1988cited by this paper
• Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.

  1988cited by this paper
• Cimetidine reduces cyclosporine inhibition of interleukin-2 production.

  1988cited by this paper
• The high fidelity of DNA duplication.

  1988cited by this paper
• High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

  1988cited by this paper
• Natural killer cell activity associated with human neoplasms.

  1987cited by this paper
• Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase

  1987cited by this paper
• Mast cell histamine release induced by intermediate products of arachidonic acid metabolism.

  1987cited by this paper
• Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and functions.

  1987cited by this paper
• Histamine type-2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin-2 production.

  1987cited by this paper
• Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and functions.

  1987cited by this paper
• Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

  1987cited by this paper
• Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.

  1986cited by this paper
• Interferons in the treatment of multiple myeloma.

  1986cited by this paper
• Interferons in the treatment of multiple myeloma.

  1986cited by this paper
• Treatment of multiple myeloma with recombinant interferon alfa‐2a

  1986cited by this paper
• Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.

  1986cited by this paper
• Influence of iron on infection.

  1986cited by this paper
• Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.

  1984cited by this paper
• Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay.

  1983cited by this paper
• Biphasic pattern of bacterial infection in multiple myeloma.

  1982cited by this paper
• Opsonic activity of myeloma immuno‐globulins (mm‐lg)

  1981cited by this paper
• Incidence of pituitary adenoma in women.

  1979cited by this paper
• Hypogammaglobulinemia in experimental myeloma: the role of suppressor factors from mononuclear phagocytes.

  1977cited by this paper
• Studies on the pathogenesis of an immune defect in multiple myeloma.

  1977cited by this paper
• Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

  1975cited by this paper
• Multiple myeloma: review of 869 cases.

  1975cited by this paper
• Letter: Chronic renal disease.

  1975cited by this paper
• Agarose gel electrophoresis.

  1972cited by this paper
• Cytochemical identification of monocytes and granulocytes.

  1971cited by this paper

• Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects

  2021cites this paper
• Oral ranitidine: A promising novel therapeutic option in molluscum contagiosum in children

  2019cites this paper
• Oral Ranitidine in Molluscum Contagiosum: A Novel Common Treatment Modality for a Common Disease

  2018cites this paper
• Acid-Suppressive Therapy and Risk of Infections: Pros and Cons

  2017cites this paper
• Histamine-2 receptor antagonists as immunomodulators: new therapeutic views?

  1996cites this paper
• Histaminergic Regulation of Natural Killer Cell‐Mediated Clearance of Tumour Cells in Mice

  1996cites this paper
• The effect of histamine type-2 receptor antagonists on posttraumatic immune competence.

  1995cites this paper
• Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations.

  1991cites this paper
• Ranitidine improves certain cellular immune responses in asymptomatic HIV-infected individuals.

  1991cites this paper